Cigna Group: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Feb 25, 2021 and accepted by EDGAR at Feb 25, 2021, 12:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $160.40bn | us-gaap:Revenues |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $103.48bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months2020-01-01 to 2020-12-31 | $14.07bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $8.15bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $2.38bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | $8.49bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $22.96 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $23.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 368,389,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $10.35bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 12 months2020-01-01 to 2020-12-31 | $4.04bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $10.18bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $27.80bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $155.45bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $36.02bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $105.06bn | us-gaap:Liabilities |
| Current portion of debt | At period end2020-12-31 | $3.37bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2020-12-31 | $1.03bn | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2020-12-31 | $50.32bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001739940-21-000007. Last ingested by Listed: Nov 5, 2026, 13:13 ET. Listed shows no prices and gives no investment advice.